Dr. Berkowitz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2401 W University Ave
Muncie, IN 47303Phone+1 765-281-2030
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2008 - 2011
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2005 - 2008
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2005
Certifications & Licensure
IN State Medical License 2018 - 2025- IN State Medical License 2018 - 2023
CA State Medical License 2011 - 2020
NY State Medical License 2007 - 2012- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- 48 citationsSafety, efficacy, and pharmacokinetics/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia/lymphomaJonathan L. Berkowitz, John E. Janik, Donn M. Stewart, Elaine S. Jaffe, Maryalice Stetler-Stevenson
Clinical Immunology. 2014-12-01 - 9 citationsAdult T-cell leukemia/lymphoma with Epstein-Barr virus-positive Hodgkin-like cells.Girish Venkataraman, Jonathan L. Berkowitz, John C. Morris, John E. Janik, Mark Raffeld
Human Pathology. 2011-07-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
